Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001683168-25-007873
Filing Date
2025-10-31
Accepted
2025-10-31 16:20:12
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS xenetic_defa14a.htm DEFA14A 12110
2 GRAPHIC image_001.jpg GRAPHIC 162914
3 GRAPHIC image_002.jpg GRAPHIC 109093
  Complete submission text file 0001683168-25-007873.txt   388151
Mailing Address 945 CONCORD ST. FRAMINGHAM MA 01701
Business Address 945 CONCORD ST. FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

EIN.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37937 | Film No.: 251440794
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)